Osteoblastomatosis of bone. A benign, multifocal osteoblastic lesion, distinct from osteoid osteoma and osteoblastoma, radiologically simulating a vascular tumor-Reference-Cited by-同舟云学术

Osteoblastomatosis of bone. A benign, multifocal osteoblastic lesion, distinct from osteoid osteoma and osteoblastoma, radiologically simulating a vascular tumor

Published:2006-04-25 Issue:3 Volume:36 Page:237-247
ISSN:0364-2348
Container-title:Skeletal Radiology
language:en
Short-container-title:Skeletal Radiol

Author:

Kyriakos Michael,El-Khoury Georges Y.,McDonald Douglas J.,Buckwalter Joseph A.,Sundaram Murali,DeYoung Barry,O’Brien Michael P.

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s00256-006-0113-5.pdf

Reference51 articles.

1. Dorfman HD, Czerniak B. Bone tumors. St. Louis: CV Mosby; 1998. p. 441–481

2. Mirra JM. Bone tumors. Clinical, radiologic, and pathologic correlations. Philadephia:Lea & Febiger; 1989

3. Mulder JD, Kroon HM, Schütte HE, Taconis WK. Radiologic atlas of bone tumors. Amsterdam: Elsevier; 1993

4. Schajowicz F. Tumors and tumorlike lesions of bone. Pathology, radiology, and treatment. 2nd edition. Berlin:Springer; 1994

5. Unni KK. Dahlin’s bone tumors. General aspects and data on 11,087 cases. 5th ed. Philadelphia:Lippincott-Raven; 1996

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A RARE CASE OF BILATERAL OSTEOMA OF THE MANDIBLE;DENTAL JOURNAL OF INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES;2022-02-15

2. Spinal osteoblastoma: a retrospective study of 35 patients’ imaging findings with an emphasis on MRI;Insights into Imaging;2020-11-23

3. Osteoblastomatosis: an unusual diagnosis and treatment;Skeletal Radiology;2018-02-15

4. Benigne Tumoren und tumorähnliche Veränderungen (Tumor-like Lesions) I;Skelettradiologie;2017

5. Clinical management of a challenging malignancy, osteoblastoma-like osteosarcoma: a report of four cases and a review of the literature;Therapeutics and Clinical Risk Management;2016-08